CN104904964A - Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof - Google Patents
Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof Download PDFInfo
- Publication number
- CN104904964A CN104904964A CN201510394023.XA CN201510394023A CN104904964A CN 104904964 A CN104904964 A CN 104904964A CN 201510394023 A CN201510394023 A CN 201510394023A CN 104904964 A CN104904964 A CN 104904964A
- Authority
- CN
- China
- Prior art keywords
- parts
- apocyni veneti
- folium apocyni
- blood
- health protection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 42
- 241001122767 Theaceae Species 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title claims description 19
- 150000002632 lipids Chemical class 0.000 title abstract description 9
- 230000003247 decreasing effect Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 76
- 239000002994 raw material Substances 0.000 claims abstract description 22
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 21
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 20
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 20
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 20
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 20
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 20
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 20
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 20
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 20
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 20
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 20
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 20
- 241000830535 Ligustrum lucidum Species 0.000 claims abstract description 20
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 16
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 15
- 235000008113 selfheal Nutrition 0.000 claims abstract description 15
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 14
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 14
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 14
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 14
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 13
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 13
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 13
- 235000013976 turmeric Nutrition 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 60
- 230000002218 hypoglycaemic effect Effects 0.000 claims description 35
- 239000000284 extract Substances 0.000 claims description 27
- 230000008901 benefit Effects 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 17
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 17
- 229940079593 drug Drugs 0.000 claims description 17
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 16
- 239000009636 Huang Qi Substances 0.000 claims description 15
- 241000718543 Ormosia krugii Species 0.000 claims description 15
- 241000208966 Polygala Species 0.000 claims description 15
- 244000153955 Reynoutria sachalinensis Species 0.000 claims description 15
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- 241000488974 Loranthus Species 0.000 claims description 14
- 241000219784 Sophora Species 0.000 claims description 14
- 230000003071 parasitic effect Effects 0.000 claims description 14
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims description 13
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 11
- 239000008187 granular material Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 8
- 239000012535 impurity Substances 0.000 claims description 8
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 7
- 235000011837 pasties Nutrition 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000003205 fragrance Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 229920001353 Dextrin Polymers 0.000 claims description 5
- 239000004375 Dextrin Substances 0.000 claims description 5
- 240000007890 Leonurus cardiaca Species 0.000 claims description 5
- 235000019425 dextrin Nutrition 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000003306 harvesting Methods 0.000 claims description 4
- 238000005057 refrigeration Methods 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 241001055174 Asterinides folium Species 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 239000003480 eluent Substances 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 91
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 47
- 206010020772 Hypertension Diseases 0.000 abstract description 32
- 241000207925 Leonurus Species 0.000 abstract description 9
- 230000036772 blood pressure Effects 0.000 abstract description 9
- 210000003038 endothelium Anatomy 0.000 abstract description 6
- 230000004089 microcirculation Effects 0.000 abstract description 6
- 230000007423 decrease Effects 0.000 abstract description 4
- 244000135727 Abrus pulchellus subsp cantoniensis Species 0.000 abstract description 3
- 235000017112 Abrus pulchellus subsp cantoniensis Nutrition 0.000 abstract description 3
- 241001080798 Polygala tenuifolia Species 0.000 abstract description 2
- 240000001341 Reynoutria japonica Species 0.000 abstract description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000628997 Flos Species 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 230000002227 vasoactive effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 93
- 239000008280 blood Substances 0.000 description 93
- 210000004185 liver Anatomy 0.000 description 33
- 235000019197 fats Nutrition 0.000 description 30
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 28
- 241000700159 Rattus Species 0.000 description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 21
- 241000699666 Mus <mouse, genus> Species 0.000 description 20
- 230000001737 promoting effect Effects 0.000 description 20
- 208000004880 Polyuria Diseases 0.000 description 17
- 230000035619 diuresis Effects 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 16
- 230000037396 body weight Effects 0.000 description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 16
- 210000003734 kidney Anatomy 0.000 description 16
- 230000036407 pain Effects 0.000 description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 14
- 102000004877 Insulin Human genes 0.000 description 14
- 108090001061 Insulin Proteins 0.000 description 14
- 230000001077 hypotensive effect Effects 0.000 description 14
- 229940125396 insulin Drugs 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 241000722949 Apocynum Species 0.000 description 12
- 241001465754 Metazoa Species 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N glipizide Chemical compound C1=NC(C)=CN=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZJJXGWJIGJFDTL-UHFFFAOYSA-N 0.000 description 12
- 239000008103 glucose Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 230000017531 blood circulation Effects 0.000 description 11
- 230000001631 hypertensive effect Effects 0.000 description 11
- 206010030113 Oedema Diseases 0.000 description 10
- 241000736199 Paeonia Species 0.000 description 10
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 201000005577 familial hyperlipidemia Diseases 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 230000007774 longterm Effects 0.000 description 10
- 235000012000 cholesterol Nutrition 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 7
- 208000002173 dizziness Diseases 0.000 description 7
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 7
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 7
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 7
- 235000005493 rutin Nutrition 0.000 description 7
- 229960004555 rutoside Drugs 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 208000031226 Hyperlipidaemia Diseases 0.000 description 6
- 208000001953 Hypotension Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 208000021822 hypotensive Diseases 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 210000003462 vein Anatomy 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 244000201986 Cassia tora Species 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 5
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 5
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 230000001914 calming effect Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 5
- 230000007170 pathology Effects 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 235000005875 quercetin Nutrition 0.000 description 5
- 229960001285 quercetin Drugs 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 5
- 239000002550 vasoactive agent Substances 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- 244000080767 Areca catechu Species 0.000 description 4
- 235000006226 Areca catechu Nutrition 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010007191 Capillary fragility Diseases 0.000 description 4
- 235000014552 Cassia tora Nutrition 0.000 description 4
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 206010022998 Irritability Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- IKGXIBQEEMLURG-UHFFFAOYSA-N Rutin Chemical compound OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-UHFFFAOYSA-N 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 235000013339 cereals Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 230000000249 desinfective effect Effects 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 229930003944 flavone Natural products 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 235000011949 flavones Nutrition 0.000 description 4
- 229960001381 glipizide Drugs 0.000 description 4
- 208000006750 hematuria Diseases 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 231100000862 numbness Toxicity 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000000153 supplemental effect Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 235000014101 wine Nutrition 0.000 description 4
- HNOSJVWYGXOFRP-UNPOXIGHSA-N (5r,8s,9s,10s,11s,14r)-11-hydroxy-4,4,8,10,14-pentamethyl-17-[(2r,4s,5r)-4,5,6-trihydroxy-6-methylheptan-2-yl]-1,2,5,6,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-3-one Chemical compound C([C@@]12C)CC(=O)C(C)(C)[C@@H]1CC[C@@]1(C)[C@H]2[C@@H](O)CC2=C([C@@H](C[C@H](O)[C@@H](O)C(C)(C)O)C)CC[C@@]21C HNOSJVWYGXOFRP-UNPOXIGHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HNOSJVWYGXOFRP-UHFFFAOYSA-N Alisol A Natural products CC12CCC(=O)C(C)(C)C1CCC1(C)C2C(O)CC2=C(C(CC(O)C(O)C(C)(C)O)C)CCC21C HNOSJVWYGXOFRP-UHFFFAOYSA-N 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 208000007241 Experimental Diabetes Mellitus Diseases 0.000 description 3
- 240000001972 Gardenia jasminoides Species 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 3
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010046788 Uterine haemorrhage Diseases 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 208000012886 Vertigo Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000496 cardiotonic agent Substances 0.000 description 3
- 230000003177 cardiotonic effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 210000004351 coronary vessel Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000002024 ethyl acetate extract Substances 0.000 description 3
- 239000003337 fertilizer Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 235000013922 glutamic acid Nutrition 0.000 description 3
- 239000004220 glutamic acid Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 3
- 238000011552 rat model Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000000697 sensory organ Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 239000004474 valine Substances 0.000 description 3
- 235000014393 valine Nutrition 0.000 description 3
- 231100000889 vertigo Toxicity 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000242 Abortion threatened Diseases 0.000 description 2
- 206010002368 Anger Diseases 0.000 description 2
- 241000185686 Apocynum venetum Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241001233914 Chelidonium majus Species 0.000 description 2
- 241000123589 Dipsacus Species 0.000 description 2
- 206010053155 Epigastric discomfort Diseases 0.000 description 2
- 208000004929 Facial Paralysis Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 206010067715 Gastrointestinal sounds abnormal Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 208000035150 Hypercholesterolemia Diseases 0.000 description 2
- 102000003746 Insulin Receptor Human genes 0.000 description 2
- 108010001127 Insulin Receptor Proteins 0.000 description 2
- WNGSUWLDMZFYNZ-UHFFFAOYSA-N Leonurine Chemical compound COC1=CC(C(=O)OCCCCN=C(N)N)=CC(OC)=C1O WNGSUWLDMZFYNZ-UHFFFAOYSA-N 0.000 description 2
- 235000008569 Linum perenne Nutrition 0.000 description 2
- 244000236527 Linum perenne Species 0.000 description 2
- 241000218922 Magnoliophyta Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 241000219050 Polygonaceae Species 0.000 description 2
- 244000197580 Poria cocos Species 0.000 description 2
- 235000008599 Poria cocos Nutrition 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- -1 Rytub) Chemical compound 0.000 description 2
- NTFQHAKUNDRGJR-UHFFFAOYSA-N Sophoradiol Natural products CC1(C)CC(O)C2(C)CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1 NTFQHAKUNDRGJR-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 101000693619 Starmerella bombicola Lactone esterase Proteins 0.000 description 2
- 208000005985 Threatened Abortion Diseases 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000210 abortion Diseases 0.000 description 2
- 231100000176 abortion Toxicity 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000003905 agrochemical Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000489 anti-atherogenic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000001773 anti-convulsant effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003356 anti-rheumatic effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 239000003435 antirheumatic agent Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000003143 atherosclerotic effect Effects 0.000 description 2
- 210000003719 b-lymphocyte Anatomy 0.000 description 2
- 230000003542 behavioural effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000036471 bradycardia Effects 0.000 description 2
- 208000006218 bradycardia Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 239000008121 dextrose Substances 0.000 description 2
- 238000013118 diabetic mouse model Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 208000001130 gallstones Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 235000021142 long-term diet Nutrition 0.000 description 2
- 231100001252 long-term toxicity Toxicity 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000005259 peripheral blood Anatomy 0.000 description 2
- 239000011886 peripheral blood Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003716 rejuvenation Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- ZEGUWBQDYDXBNS-FVFJQADASA-N sophoradiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)[C@H](O)CC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C ZEGUWBQDYDXBNS-FVFJQADASA-N 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- GBJKHDVRXAVITG-UNPOXIGHSA-N Alisol B Chemical compound O([C@@H]1[C@@H](O)C[C@@H](C)C=2CC[C@]3(C)[C@@]4(C)CC[C@H]5C(C)(C)C(=O)CC[C@]5(C)[C@@H]4[C@@H](O)CC3=2)C1(C)C GBJKHDVRXAVITG-UNPOXIGHSA-N 0.000 description 1
- 206010002953 Aphonia Diseases 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000062995 Cassia occidentalis Species 0.000 description 1
- 235000001948 Cassia occidentalis Nutrition 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000490229 Eucephalus Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 241000212321 Levisticum Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- JYDNKGUBLIKNAM-UHFFFAOYSA-N Oxyallobutulin Natural products C1CC(=O)C(C)(C)C2CCC3(C)C4(C)CCC5(CO)CCC(C(=C)C)C5C4CCC3C21C JYDNKGUBLIKNAM-UHFFFAOYSA-N 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000208977 Polygalaceae Species 0.000 description 1
- 244000292697 Polygonum aviculare Species 0.000 description 1
- 235000006386 Polygonum aviculare Nutrition 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000052209 Triplasis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229930188824 alisol Natural products 0.000 description 1
- QMCLOHXDDPMAMI-UHFFFAOYSA-N alisol B Natural products CC(C)C(=O)C(O)CC(C)C1=C2CC(O)C3C4(C)CCC(=O)C(C)(C)C4CCC3(C)C2(C)CC1 QMCLOHXDDPMAMI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000002744 anti-aggregatory effect Effects 0.000 description 1
- 230000000049 anti-anxiety effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- FVWJYYTZTCVBKE-ROUWMTJPSA-N betulin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(CO)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C FVWJYYTZTCVBKE-ROUWMTJPSA-N 0.000 description 1
- MVIRREHRVZLANQ-UHFFFAOYSA-N betulin Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C2CC=C4C5C(CCC5(CO)CCC34C)C(=C)C)C1(C)C MVIRREHRVZLANQ-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000132 chronic toxicity testing Toxicity 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 239000003866 digestant Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000010218 duhuo jisheng Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 210000004700 fetal blood Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 230000009246 food effect Effects 0.000 description 1
- 235000021471 food effect Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a folium apocyni veneti health tea capable of decreasing sugar and lipid. The folium apocyni veneti health tea is prepared from the following raw materials in parts by weight: 10 to 50 parts of folium apocyni veneti, 10 to 20 parts of rhizoma alismatis, 10 to 20 parts of leonurus, 10 to 20 parts of polygonum cuspidatum, 10 to 20 parts of semen cassiae, 10 to 20 parts of abrus cantoniensis hance, 10 to 20 parts of hawthorn, 10 to 20 parts of turmeric, 10 to 20 parts of fructus gardenia, 10 to 20 parts of loranthus parasiticus, 10 to 20 parts of flos sophorae, 10 to 20 parts of glossy privet fruit, 10 to 20 parts of polygala tenuifolia, 10 to 20 parts of gynostemma pentaphylla, 10 to 20 parts of selfheal, 10 to 20 parts of lotus leaf, 10 to 20 parts of radix paeoniae alba, and 10 to 20 parts of astragalus membranaceus. According to the folium apocyni veneti health tea, the traditional Chinese medicines are multi-target by being compared with Western medicine which is fast to act and high in effect, and the traditional Chinese medicines can decrease the blood pressure and treat other pathological links of diabetes and high blood pressure; therefore, the folium apocyni veneti health tea has the effects of improving microcirculation, decreasing the lipid and resisting oxidation, protecting endothelium, and modifying vaso-active substances.
Description
Technical field
The present invention relates to the health products containing deriving from plant composition, particularly a kind of Folium Apocyni Veneti health protection tea and preparation method thereof of hypoglycemic.
Background technology
Along with the raising of people's living standard, the illness rate of China coronary heart disease crowd is also improving constantly, and sicken age is tending towards rejuvenation, and coronary heart disease has become the killer of serious threat people life.The main cause of coronary heart disease is coronary atherosclerosis, and atherosclerotic is also the one of the main reasons of other position arterial disease.Causing arteriosclerotic hazards has a lot, such as hyperlipidemia (especially hypercholesterolemia), diabetes, and hypertension is fat or overweight, smoking etc., and wherein hypercholesterolemia is the most important hazards of atherosclerotic.One of most important progress of modern medicine is exactly specify that to lower blood cholesterol (TC) especially LDL.C, can significantly reduce coronary heart disease case fatality rate.
Day by day flourishing due to economy, the continuous lifting of modern's living standard, cause people too much have deep love for enjoy, do not notice that the life style of oneself, behavioural habits, diet are had a liking for, thus the disease caused.Society with fast rhythm lives, the operating pressure of keen competition, serious threat is caused to the physical and mental health of modern, add that long-term diet is unreasonable, that is: smart grain replaces coarse food grain completely, the agricultural chemicals remained in the absorption of a large amount of three height (high heat, high protein, higher fatty acid), more than three (anticorrisive agent is many, flavoring agent is many, hormone many) food and food, chemical fertilizer stockpiling in vivo, add air, pollution of waterhead and amount of exercise less than normal, obesity and diabetes have just become the rich man's disease of city gang.
When the reason that diabetes cause blood fat to increase is due to diabetes patient's insufficient insulin, body lactonase activity lowers, and therefore easily blood fat increases.Diabetes itself also accompany fat, protein and water, dielectric disorder except carbohydrate metabolism disturbance simultaneously on the other hand.Often there is free fatty to mobilize out from fat depot, triglycerides and FFA concentrations in blood are increased.Diabetes B people takes food too much on the one hand again, and motion is few, and impel lipid synthesis in body to increase, this is also the reason causing blood fat to increase.And fat companion's high fat of blood person, because insulin receptor number reduces relatively, thus produce insulin resistance, easy induced Diabetic.Diabetes are a kind of syndrome due to insulin secretion, insulin action or both carbohydrate, protein and fat metabolic disturbances simultaneously caused by existing defects.Essential characteristic is that blood sugar increases, long-term damage is dysfunction and the exhaustion of various organ, comprise the vascular conditions of constantly progress, namely PVR, blind, ephrosis, renal failure, DPN companion foot ulcers, amputation and autonomic nervous function change, and also have the danger of ever-increasing cardiovascular, the cerebrovascular and peripheral angiopathy.
Folium Apocyni Veneti, another name: bluish dogbane, wartwort fiber crops, wild tealeaves, sage, wild flax; Latin literary fame: dogbane leaf. Angiospermae, Dicotyledoneae, the leaf of bluish dogbane, many shrinkages are curling, some fragmentations, in ellipticity lanceolar or oval shape lanceolar after intact leaf flattens, long 2 ~ 5cm, wide 0.5 ~ 2cm, light green or celadon, tip is blunt, has little awns point, the blunt circle of base portion or wedge shape, edge tool serration, Chang Fanjuan, two sides is without hair, and vein is in lower surface projection; Petiole is thin, is about 4mm.Matter is crisp.Its gas is micro-, lightly seasoned sweet, bitter, cold.Return Liver Channel.Function with cure mainly: flat liver is calmed the nerves, clearing away heat and promoting diuresis.For dizziness due to hyperactivity of liver-YANG, palpitation and insomnia, edema oliguria; High blood pressure, neurasthenia, ephritis edema.
Folium Apocyni Veneti is cold in nature. and taste is sweet, bitter, and flat liver is calmed the nerves, clearing away heat and promoting diuresis.Main component rutin sophorin, catechu rope, isoquercitrin rope, glutamic acid, alanine, valine, potassium chloride etc., wherein antihypertensive compositions is Quercetin, general flavone, have hypotensive, strengthen capillary resistance, reduce capillary fragility, fall that blood refers to, coronary artery dilator increases coronary blood flow effect.And pass through VSMC voltage dependent Ca 2+ channels and the effect of receptor-operated Ca2+ passage double inhibition, reduce Intracellular signaling level, this may be one of vasodilator Hypotensive Mechanism.
Pharmacological action: Folium Apocyni Veneti decoction has hypotensive effect; Root of Apocynum venetum L decoction has cardiotonic; Folium Apocyni Veneti medicinal extract has calmness, anticonvulsant action, and have stronger diuresis, reduce blood fat, immunity moderation, anti-ageing and suppress the effect such as influenza virus.Bad reaction: Folium Apocyni Veneti preparation is for oral administration can occur nausea,vomiting,diarrhea, epigastric discomfort, also can occur bradycardia and proiosystole.Dizziness can be there is when inhaling bluish dogbane cigarette, choke cough, feel sick, insomnia etc.
Modern selects some health foods or functional food to be to improve the health.The function of health products mainly improves blood circulation of human body, enriching yin and nourishing kidney, improves body immunity.The various health products sold on the market now, dragons and fishes jumbled together for medicine, and the amusement of great majority just false propaganda, what have does not only have health-care components, also causes the huge injury of the person.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.How the efficacy exertion of Folium Apocyni Veneti not being injured human body again to maximum, and obviously improve mouthfeel, people can be accepted, is our problem in the urgent need to address.Chinese medicine can play assistant hypoglycemic step-down, lipopenicillinase, reduces Western medicine side effect, and reduce Western medicine intake, the effect of consolidate curative effect, as the health-care effect that health products supplemental treatment has had.In a word, though Chinese medicine hypoglycemic hypotensive effect does not have, Western medicine speed is fast, effect is strong, and more its effect harrows a little; while step-down, diabetes, other pathology links hypertensive can also be taken into account, have improve microcirculation, lipopenicillinase is anti-oxidant; protection endothelium, regulates the effects such as vaso-active substance.Therefore, Chinese medicine obviously can improve diabetes, hypertensive clinical symptoms, improves the quality of life of patient, along with further developing of scientific and technical means, believes that Chinese medicine hypoglycemic hypotensive effect prospect is boundless.
Summary of the invention
Technical problem to be solved by this invention is, Chinese medicine can play assistant hypoglycemic step-down, lipopenicillinase, reduces Western medicine side effect, and reduce Western medicine intake, the effect of consolidate curative effect, as the health-care effect that health products supplemental treatment has had.In a word, though Chinese medicine hypoglycemic hypotensive effect does not have, Western medicine speed is fast, effect is strong, and more its effect harrows a little; while step-down, diabetes, other pathology links hypertensive can also be taken into account, have improve microcirculation, lipopenicillinase is anti-oxidant; protection endothelium, regulates the effects such as vaso-active substance.Therefore, Chinese medicine obviously can improve diabetes, hypertensive clinical symptoms, improves the quality of life of patient.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.Folium Apocyni Veneti is cold in nature. and taste is sweet, bitter, and flat liver is calmed the nerves, clearing away heat and promoting diuresis.Main component rutin sophorin, catechu rope, isoquercitrin rope, glutamic acid, alanine, valine, potassium chloride etc., wherein antihypertensive compositions is Quercetin, general flavone, have hypotensive, strengthen capillary resistance, reduce capillary fragility, fall that blood refers to, coronary artery dilator increases coronary blood flow effect.The micro-bitter glycol of the present invention; Add some promoting blood circulation and removing blood stasis, mouthfeel is light, makes people be easy to the Chinese medicine accepted, can reach effect of hypoglycemic preferably.
For solving above-mentioned technical barrier, the invention provides a kind of Folium Apocyni Veneti health protection tea of hypoglycemic, described in it, Folium Apocyni Veneti health protection tea comprises the raw material of following parts by weight: Folium Apocyni Veneti 10 ~ 50 parts, rhizoma alismatis 10 ~ 20 parts, motherwort 10 ~ 20 parts, giant knotweed 10 ~ 20 parts, cassia seed 10 ~ 20 parts, Canton love-pea vine 10 ~ 20 parts, hawthorn 10 ~ 20 parts, 10 ~ 20 parts, turmeric, cape jasmine 10 ~ 20 parts, parasitic loranthus 10 ~ 20 parts, 10 ~ 20 parts, sophora flower, the fruit of glossy privet 10 ~ 20 parts, polygala root 10 ~ 20 parts, gynostemma pentaphylla 10 ~ 20 parts, selfheal 10 ~ 20 parts, 10 ~ 20 parts, lotus leaf, the root of herbaceous peony 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts.
The Folium Apocyni Veneti health protection tea of described hypoglycemic, in Folium Apocyni Veneti health protection tea described in it, the parts by weight of various raw material can be: Folium Apocyni Veneti 10 ~ 40 parts, rhizoma alismatis 10 ~ 15 parts, motherwort 10 ~ 15 parts, giant knotweed 10 ~ 15 parts, cassia seed 10 ~ 15 parts, Canton love-pea vine 10 ~ 15 parts, hawthorn 10 ~ 15 parts, 10 ~ 15 parts, turmeric, cape jasmine 10 ~ 15 parts, parasitic loranthus 10 ~ 20 parts, 10 ~ 20 parts, sophora flower, the fruit of glossy privet 10 ~ 20 parts, polygala root 10 ~ 20 parts, gynostemma pentaphylla 10 ~ 20 parts, selfheal 10 ~ 20 parts, 10 ~ 20 parts, lotus leaf, the root of herbaceous peony 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts.
The Folium Apocyni Veneti health protection tea of described hypoglycemic, in Folium Apocyni Veneti health protection tea described in it, the parts by weight of various raw material can also be: Folium Apocyni Veneti 10 ~ 30 parts, rhizoma alismatis 10 ~ 20 parts, motherwort 10 ~ 20 parts, giant knotweed 10 ~ 20 parts, cassia seed 10 ~ 20 parts, Canton love-pea vine 10 ~ 20 parts, hawthorn 10 ~ 20 parts, 10 ~ 20 parts, turmeric, cape jasmine 10 ~ 20 parts, parasitic loranthus 10 ~ 15 parts, 10 ~ 15 parts, sophora flower, the fruit of glossy privet 10 ~ 15 parts, polygala root 10 ~ 15 parts, gynostemma pentaphylla 10 ~ 15 parts, selfheal 10 ~ 15 parts, 10 ~ 15 parts, lotus leaf, the root of herbaceous peony 10 ~ 15 parts, the Radix Astragali 10 ~ 15 parts.
For solving the problems of the technologies described above, the present invention also provides the preparation method of a kind of Folium Apocyni Veneti health protection tea of hypoglycemic, and the preparation process of described Folium Apocyni Veneti health protection tea comprises following aspect:
A. Folium Apocyni Veneti harvesting, knead, Titian;
B. heat extraction 2 times by all the other raw material soaking ethanol described, dregs of a decoction extracting in water 2 times again, merges;
C. the concentrate concentrated extract of all the other raw materials is become medicinal extract, add honey or dextrin makes granule, pulvis or paste;
D. granule, pulvis or paste that the Folium Apocyni Veneti prepared and above-mentioned steps obtain are mixed, pack after ultraviolet sterilization.
In described step a, at annual harvesting in summer Folium Apocyni Veneti, plucked to spread out and shone or dry, sieve discarding stalk, raises clean impurity; First knead 10-15 minute with the little fire of iron pan, be then put into fragrance extracting machine Titian 10-20 minute.
In described step b, all the other raw medicinal materials can be mixed, steep in ethanol, soak more than 2 hours, add the alcohol extract 2 times of 8 times amount of Folium Apocyni Veneti gross weight, 6 times amount respectively, extraction time is 2 hours, 1 hour; Merge No. 2 extracts, extract is centrifugal by tubular type, obtains centrifugate, and centrifugate is crossed D 101 macroreticular resin and adsorbed, and first washes removal of impurities with water, then carries out wash-out with the ethanol of 70%, collects eluent, merges standing.
In described step c, above-mentioned steps can be obtained extract, insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the medicinal extract of 1.50, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Refrigeration liquid is added the filter aid diatomite of 0.3%, filter, medicinal extract is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.2g crude drug amount; Paste after concentrated adds dextrin or granule made by honey.
For solving the problems of the technologies described above, the present invention reoffers the preparation method of a kind of Folium Apocyni Veneti health protection tea of hypoglycemic, and the step that city pulvis prepared by other raw materials can also be:
A, get other raw materials and put into ethanol and soak, heat is extracted 3 times;
B, extract is positioned in inspissator concentrated, is then dried to pulvis.
In described step a, all the other bulk drugs can be soaked in ethanol 12 hours, then put into extractor heating and boil 1 hour, filter, filtrate is for subsequent use; Filter residue adds ethanol, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filter residue adds ethanol again, and half an hour is boiled in third time heating, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge leaching liquor, are condensed into pasty state.
In described step b, the raw material pasty state liquid that can extract, reducing pressure after reclaiming ethanol, it is concentrated to put into inspissator, and by gained concentrate adjustment proportion to 1.46, decompression, the pasty state liquid after concentrated is put into drying machine and is dried to pulvis.
The technique effect that the present invention is useful is, Chinese medicine can play assistant hypoglycemic step-down, lipopenicillinase, reduces Western medicine side effect, and reduce Western medicine intake, the effect of consolidate curative effect, as the health-care effect that health products supplemental treatment has had.In a word, though Chinese medicine hypoglycemic hypotensive effect does not have, Western medicine speed is fast, effect is strong, and more its effect harrows a little; while step-down, diabetes, other pathology links hypertensive can also be taken into account, have improve microcirculation, lipopenicillinase is anti-oxidant; protection endothelium, regulates the effects such as vaso-active substance.Therefore, Chinese medicine obviously can improve diabetes, hypertensive clinical symptoms, improves the quality of life of patient.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.The micro-bitter glycol of the present invention; Add some promoting blood circulation and removing blood stasis, mouthfeel is light, makes people be easy to the Chinese medicine accepted, can reach effect of hypoglycemic preferably.
Detailed description of the invention
High fat of blood can cause blood vessel embolism; Hypertension can cause cerebral hemorrhage and rupture of blood vessel in brain; Hyperglycaemia can cause diabetes.The World Health Organization once clearly proposed, and prevented the first line of defence of cardiovascular disease from reducing " three is high " exactly and controlling " three is high ".A lot of diabetes patient is with hyperlipidemia, and therefore diabetes and hyperlipidemia, people call that sister is sick usually, and think that high fat of blood is the secondary disease of diabetes.The diabetic of about 40% has disorders of lipid metabolism according to statistics.Be characterized in that triglycerides increases to reduce with HDL.When the reason that diabetes cause blood fat to increase is due to diabetes patient's insufficient insulin, body lactonase activity lowers, and therefore easily blood fat increases.Diabetes itself also accompany fat, protein and water, dielectric disorder except carbohydrate metabolism disturbance simultaneously on the other hand.Often there is free fatty to mobilize out from fat depot, triglycerides and FFA concentrations in blood are increased.Diabetes B people takes food too much on the one hand again, and motion is few, and impel lipid synthesis in body to increase, this is also the reason causing blood fat to increase.And fat companion's high fat of blood person, because insulin receptor number reduces relatively, thus produce insulin resistance, easy induced Diabetic.Blood fat increased perosn also easily causes the heart, cerebrovascular complication.
Day by day flourishing due to economy, the continuous lifting of modern's living standard, cause people too much have deep love for enjoy, do not notice that the life style of oneself, behavioural habits, diet are had a liking for, thus the disease caused.Society with fast rhythm lives, the operating pressure of keen competition, serious threat is caused to the physical and mental health of modern, people more than half is made to be in sub-health state, show as: dizzy, nervous, weak, poor appetite, failure of memory, insomnia, indifferent to etc. to thing, in addition, long-term diet is unreasonable, that is: smart grain replaces coarse food grain completely, a large amount of three height (high heat, high protein, higher fatty acid), more than three, (anticorrisive agent is many, flavoring agent is many, hormone is many) agricultural chemicals residual in the absorption of food and food, chemical fertilizer stockpiling in vivo, add air, pollution of waterhead and amount of exercise less than normal, go down to make three high disease (hypertension for a long time like this, hyperglycaemia, high fat of blood), cardiovascular and cerebrovascular disease, cancers etc. so-called " modern civilization diseases " rise rapidly, and constantly rejuvenation, the serious health and lives jeopardizing the mankind.
Chinese medicine can play secondary buck, lipopenicillinase, reduces Western medicine side effect, reduces Western medicine intake, the effect of consolidate curative effect.In a word, though Chinese medicine for lowering high blood pressure effect does not have, Western medicine speed is fast, effect is strong, and more its effect harrows a little; while step-down, other pathology links hypertensive can also be taken into account, have improve microcirculation, lipopenicillinase is anti-oxidant; protection endothelium, regulates the effects such as vaso-active substance.Therefore, Chinese medicine can obviously improve hypertensive clinical symptoms, improves the quality of life of patient, along with further developing of scientific and technical means, believes that Chinese medicine for lowering high blood pressure effect prospect is boundless.
In side, giant knotweed, Folium Apocyni Veneti have calming the liver to stop the wind effect, with thinking monarch.Cassia seed nature and flavor Cheng Ping, function is calming the liver, heat extraction improving eyesight, share with polygala root, selfheal, strengthens calming the liver to stop the wind power.Cape jasmine is ensuringd proper downward flow of the blood, and is ministerial drug altogether.Fruit of glossy privet clearing heat-fire, make the heat of Liver Channel unlikely on disturb; Canton love-pea vine is clearing heat and detoxicating, activating blood and promoting diuresis, and parasitic loranthus tonifies the liver and kidney; Polygala root tranquilizing the mind, is adjutant.Close and with it, become calming the liver to stop the wind altogether, heat clearing and blood circulation promoting, the side of the hypoglycemic that tonifies the liver and kidney
Folium Apocyni Veneti, another name: bluish dogbane, wartwort fiber crops, wild tealeaves, sage, wild flax; Latin literary fame: dogbane leaf. Angiospermae, Dicotyledoneae, the leaf of bluish dogbane, many shrinkages are curling, some fragmentations, in ellipticity lanceolar or oval shape lanceolar after intact leaf flattens, long 2 ~ 5cm, wide 0.5 ~ 2cm, light green or celadon, tip is blunt, has little awns point, the blunt circle of base portion or wedge shape, edge tool serration, Chang Fanjuan, two sides is without hair, and vein is in lower surface projection; Petiole is thin, is about 4mm.Matter is crisp.Its gas is micro-, lightly seasoned sweet, bitter, cold.Return Liver Channel.Function with cure mainly: flat liver is calmed the nerves, clearing away heat and promoting diuresis.For dizziness due to hyperactivity of liver-YANG, palpitation and insomnia, edema oliguria; High blood pressure, neurasthenia, ephritis edema.
Pharmacological action: Folium Apocyni Veneti decoction has hypotensive effect; Root of Apocynum venetum L decoction has cardiotonic; Folium Apocyni Veneti medicinal extract has calmness, anticonvulsant action, and have stronger diuresis, reduce blood fat, immunity moderation, anti-ageing and suppress the effect such as influenza virus.Bad reaction: Folium Apocyni Veneti preparation is for oral administration can occur nausea,vomiting,diarrhea, epigastric discomfort, also can occur bradycardia and proiosystole.Dizziness can be there is when inhaling bluish dogbane cigarette, choke cough, feel sick, insomnia etc.
Clinical practice, is used for Hypertension, every daily Folium Apocyni Veneti 1 ~ 2 money, and boiling water bubble drinks as a tea; Or timing decoction sooner or later.Control 596 examples altogether, wherein alone Folium Apocyni Veneti 169 example; Unstable and use bluish dogbane instead by other depressor effects, or depressor and the same use of bluish dogbane, blood pressure to drop to a certain degree counts with the bluish dogbane person of consolidation again 427 routine.Result transference cure or show alleviator 254 example, alleviates 212 examples; Wherein blood pressure drops to below 140/90 millimetres of mercury person 143 people, and systolic pressure or diastolic pressure decline 20 millimetres of mercury above person 268 people.Efficiently reach 88.59%.Medicine time, longer then curative effect was higher, and what exceed half a year reaches 93.3%; But the curative effect of bluish dogbane and course of disease length are without obvious relation.To headache, dizzy, brain is swollen, insomnia and dreamful sleep and edema have this medicine of good mitigation comparatively suitable to I, II phase patient; Or as the adjuvant of Hypertension, have good therapeutic effect to improving symptom.
But also there is side effect: more is borborygmus, diarrhoea; Occasionally there is stomachache, have no appetite, dry, bitter taste; Indivedual appearance asthma or hepatodynia.But also there is side effect: more is borborygmus, diarrhoea; Occasionally there is stomachache, have no appetite, dry, bitter taste; Indivedual appearance asthma or hepatodynia.The Chinese medicine that the present invention adds, can well alleviate or eliminate the side effect of Folium Apocyni Veneti, applies and saferly to feel at ease, can Long-Time Service.
Parasitic loranthus bitter, sweet, property is put down.Return liver, kidney channel.Property get a breathing space and, can rise and can fall.1. filling liver kidney, strengthening the bones and muscles, wines used as antirheumatic.Lose for kidney deficiency and liver, the deficiency of blood that articular instability, the muscles and bones impotence of supporting are soft, soreness of waist and knee joint, as duhuo jisheng decoction.2. nourishing blood and preventing abortion.This product energy nourishing blood and preventing abortion gas, the solid feotus vitality of kidney tonifying, for deficiency of blood fetal irritability.These product are sweet flat, function tonifies the liver and kidney, strengthening the muscles and bones, taste sweet again can wines used as antirheumatic, treat numbness pain, by lumbago due to the kidney deficiency, fetal irritability and rheumatism with the passing of time body ressitance weakened while pathogenic factors prevailing commonly used.Parasitic loranthus is the most suitable to arthralgia due to wind-dampness, kidney deficiency and liver, soreness of waist and knee joint, and the normal and compatibility such as levisticum, the root of bidentate achyranthes is applied., women through multi-band under kidney deficiency and liver, lumbocrural pain, muscles and bones unable person empty to old man's body also often apply with the compatibility such as cassia seed, teasel root.Suffer from a deficiency of the kidney for liver lose, blood, fetal irritability under threatened abortion caused by the debility of chong and ren channels, the compatibilities such as normal and teasel root, the seed of Chinese dodder, donkey-hide gelatin.In addition, these product have hypotensive effect again, are usually used in hypertension clinically in recent years.
The root of herbaceous peony is cool in nature, and bitter acid, is slightly cold, has soft liver of enriching blood, flat liver pain relieving.Astringe yin receives the effects such as sweat, is applicable to fever due to yin deficiency, irregular menstruation, chest abdomen pain over the hypochondriac region, four limbs contraction suddenly, rushes down dysentery stomachache, spontaneous sweating, uterine bleeding, the inferior disease of band.Paeoniflorin has antibacterial, antipyretic, anti-inflammatory, increase coronary flow, improves the effect of myocardial nutritional flow, hemangiectasis, antagonism acute myocardial ischemia, Antiaggregating activity on platelet, calmness, analgesia, spasmolysis, antiulcer, adjustment blood sugar.Root of herbaceous peony decoction can suppress shigella dysenteriae, streptococcus pneumonia, Escherichia coli, typhoid bacillus, hemolytic streptococcus, Pseudomonas aeruginosa etc.The deficiency of blood deficiency of Yin, chest abdomen pain over the hypochondriac region, pain in the hepatic region, cholecystitis, gallstone pain, to rush down the condition subject such as dysentery stomachache, women's menalgia, spontaneous perspiration easy sweat night sweat, systremma, spasm of limbs pain, uneasy leg syndrome suitable edible.
The dry mature seed that cassia seed (formal name used at school: Catsia tora Linn) is pulse family annual herb plant Cassia tora or little Cassia tora.Cassia seed is also Cassia occidentalis.Cassia seed is annual suffruticose draft; The brightly yellowish look of Cassia tora, pod is elongated, four prism type; Little Cassia tora plant is less, and pod is shorter, is one of important composition.Have the merit of improving eyesight fat-reducing with it and name it.Cassia seed bitter, sweet, one-tenth, cold nature, enters liver, kidney, large intestine channel; Relax bowel, lipopenicillinase improving eyesight, treatment constipation and high fat of blood, hypertension.Clear liver and improve vision, sharp water defaecation, has laxative action, reducing blood pressure and blood fat.
Sophora flower bitter, property is put down, nontoxic, has effect of heat-clearing, cool blood, hemostasis, step-down.Significant curative effect is had to haematemesis, hematuria, hemorrhoid hemorrhage, wind-heat hot eyes, high blood pressure, hyperlipidemia, the tuberculosis of cervical lymph nodes, vascular sclerosis, stool band blood, diabetes, the retinitis, psoriasis etc.; Can also expelling parasite, control pharyngitis.Sophora flower can strengthen the resistance of capillary, reduces vasopermeability, fragility blood vessel can be made to recover flexible function, thus reducing blood lipid and prevent vascular sclerosis.The traditional Chinese medical science thinks its bitter, cold nature, returns liver, large intestine channel; Enter blood to hold back and fall, body slightly falls apart; There is cooling blood and hemostasis, effect of clearing liver-fire; Cure mainly hematochezia, hemorrhoid blood, bloody flux, hematuria, blood drenches, uterine bleeding, spits blood, bleeding from five sense organs or subcutaneous tissue, and irascibility is had a headache, red eye, swell pain, larynx numbness, aphonia, ulcer sores.And from the angle of doctor trained in Western medicine, sophora flower containing the material such as rutin (i.e. rutin sophorin, Rytub), Quercetin (Quercetin), tannin, sophoradiol (sophoradiol), vitamin A (specifically can see below contain scale).Rutin can improve the function of capillary, and keep the normal resistance of capillary, prevent because capillary fragility is excessive, too high hemorrhage, hypertension, the diabetes caused of permeability, can preventing of clothes is hemorrhage.
The fruit of glossy privet, sweet-bitter flavor, cool in nature, return liver kidney channel, there is the merit that nourishing liver and kidney, beneficial the moon nourishes blood.Modern medicine study proves, the fruit of glossy privet includes ursolic acid, sweet mellow wine, glucose, fatty wet goods, has cardiac stimulant, diuresis and hepatoprotective effect, the leucocyte decline quantity caused because of chemotherapy can be made to raise, and have inhibitory action to staphylococcus aureus, Escherichia coli.The acid of the oleanolic acid fruit of glossy privet, Ligustrum lucidum Ait, ursolic acid, stearic acid, oleic acid, sweet mellow wine, betulin, phosphatide and carbohydrate is contained as Fructus Ligustri Lucidi polysaccharide, arabinose, glucose etc. in the fruit of glossy privet, also containing 15 seed amino acids, 11 kinds of trace elements and volatilization wet goods.Research thinks that the fruit of glossy privet has hypoglycemic and reducing blood lipid and has study of anti-atherogenic effect, and antibacterial, antivirus action in addition, fruit of glossy privet decoction all has inhibitory action to staphylococcus aureus, shigella flexneri, typhoid bacillus, Pseudomonas aeruginosa and Escherichia coli.
Motherwort taste is arduous, cool.Invigorate blood circulation, silt of dispelling, menstruation regulating, disappear water.Treatment menoxenia, threatened abortion is had difficult labour, placenta retension, postpartum anemic fainting, abdominal pain due to blood stasis, and metrorrhagia and metrostaxis, rushes down blood at hematuria, and carbuncle swells sore.Motherwort containing the material such as leonurine, fumaric acid, has the effects such as promoting blood circulation for regulating menstruation, hypotensive, inducing diuresis to reduce edema.
Hawthorn: modern study hawthorn is containing materials such as carbohydrate, protein, fat, vitamin C, carrotene, starch, malic acid, citric acid, calcium and iron, there is the effects such as reducing blood lipid, blood pressure, cardiac stimulant, arrhythmia, meanwhile, hawthorn is also the good medicine of spleen benefiting and stimulating the appetite, relieving dyspepsia, phlegm reduction of blood circulation promoting.The disease such as, hernia, blood stasis full to chest diaphragm spleen, amenorrhoea has good curative effect.Flavone compound Vitexin in hawthorn, be the medicine that a kind of antitumaous effect is stronger, haw thorn extract all has certain inhibitory action to cancer cell tumor growth, propagation and infiltration metastasis.Hawthorn energy prevention and cure of cardiovascular disease, has hemangiectasis, cardiac stimulant, increase CF, improves heart vigor, stimulating central nervous system system, reduces blood pressure and cholesterol, softening blood vessel and diuresis and sedation; Prevent and treat artery sclerosis, anti-aging, anticancer effect.Crataegolic acid also has cardiotonic, also benefits to senile heart disease.Its energy appetite-stimulating indigestion-relieving, offsets carnivorous stagnant effect especially better, all have employed hawthorn in a lot of digestant medicine; Hawthorn has contraction to uterus, pregnant woman just before giving birth time have the effect expedited the emergence of, and uterine involution in postpartum can be promoted; The immunity of body can be strengthened, have anti-aging, anticancer effect.Having in hawthorn relievings asthma reduces phlegm, the composition of anti-bacteria, treatment abdominal pain diarrhea.
Polygala root (formal name used at school: Polygala tenuifolia Willd.), another name: Lush Rao, Ji Tseng-Lan, sour jujube aster, little grass, thin grass, line catechu, little grass roots, refreshing sand grass.For Polygalaceae, rogation flower.Produce northeast, North China, northwest and Central China and Sichuan.Warm in nature, bitter, pungent, the function of have intelligence development of calming the nerves, eliminate the phlegm, subsiding a swelling, the insomnia and dreamful sleep caused for breakdown of the normal physiological coordination between the heart and the kidney, forgetful palpitation with fear, wandering, expectoration is not well, sore swollen toxin, mastosis.Clinical practice crude Radix Polygalae, RADIX POLYGALAE PREPARATA and honey polygala root three kinds.
Lotus leaf dietary function: lotus leaf bitter is pungent micro-puckery, cool in nature, the thoughts of returning home, liver, the spleen channel, delicate fragrance rises loose; Have summer heat relieving and dampness eliminating, invigorating the spleen rises sun, and effect of loose stasis of blood hemostasis, cures mainly hot summer weather polydipsia, have a headache dizzy, oedema, and the few abdominal distension of food, rush down dysentery, leukorrhea, prolapse of the anus, spit blood, bleeding from five sense organs or subcutaneous tissue, spitting of blood, has blood in stool, uterine bleeding, post partum longtime lochia, traumatic blood stasis.
Turmeric turmeric, (formal name used at school: Curcuma longa L.) promoting the circulation of qi can break the stasis of blood, inducing meastruation to relieve menalgia.Cure mainly chest and abdomen swelling and pain, shoulder arm numbness pain, irregular menstruation, amenorrhoea, traumatic injury.The stasis of blood is broken in the promoting the circulation of qi of turmeric energy, inducing meastruation to relieve menalgia.Cure mainly chest and abdomen swelling and pain, shoulder arm numbness pain, irregular menstruation, amenorrhoea, traumatic injury.Yellow food colour can be extracted again; Contained curcumin can perform an analysis chemical reagent.
Giant knotweed calls sour cylinder bar, sour bucket reed, large osteosynthesis, spot village root, Classification system: Polygonumcuspidatum, polygonaceae, giant knotweed platymiscium, perennial herb.Its juice can contaminate ground rice, has a distinctive flavour.Eat with its taste acid therefore also claim " sour soup bar ".Giant knotweed contains knotweed glucoside, organic acid, glycoside, polysaccharide etc.Having clearing heat and detoxicating, cooling and heatstroke-eliminating, stomach invigorating food effect clearly, is a kind of polygonaceae plant.Clearing heat and detoxicating, normalizing gallbladder to cure jaundice, expelling wind and removing dampness, loose stasis of blood analgesic therapy, relieving cough and reducing sputum.For joint pain, jaundice with damp-heat pathogen, through closing, postpartum blood stasis does not Xia , wei lump in the abdomen, coughing with a lot of sputum, scald, traumatic injury, carbuncle sore tumefacting virus.
Canton love-pea vine latin name (Abrus cantoniensis), another name abrus cantoniensis Hance.Clearing heat and promoting diuresis, blood stasis removing analgesic.Main icteric hepatitis, stomachache, treating rheumatic ostealgia, falls and beats stasis of blood pain, breast pain Canton love-pea vine sweet and slightly bitter taste, cool in nature, returns liver, courage, stomach warp.On the impact of intestinal smooth muscle.For normal isolated rabbit ileum, Canton love-pea vine root decoction can significantly strengthen its shrinkage amplitude, and anesthetized rabbit gavage or intramuscular injection decoction also can make intestinal tube tension force in place improve, and wriggles and slightly strengthens.There is obvious inhibitory action at isolated guinea pig ileum test middle and high concentration decoction to the contraction caused by acetylcholine, but only have slight suppression caused by histamine, on person caused by barium chloride without impact.
Rhizoma alismatis taste is sweet; Light; Cold in nature.Clearing damp and promoting diuresis; Expel the heat-evil treating stranguria.Main difficult urination; Heat drenches puckery pain; Oedema turgor; Have loose bowels; Phlegmatic vertigo; Seminal emission.Rhizoma alismatis: be longer than clearing damp and promoting diuresis, expels the heat-evil, for difficult urination, and oedema turgor, the puckery pain of stranguria with turbid discharge, seminal emission, pin knee impotence is soft; Fry rhizoma alismatis, be partial to and spleen excreting dampness, for phlegm and retained fluid, rush down dysentery, vertigo.Rhizoma alismatis, Poria cocos, umbellate pore furgus; Three all can seep water dampness removing and inducing diuresis to reduce edema, and Chang Sanzhe is with using; Right rhizoma alismatis is cold in nature, can expel the heat-evil, clearly mutually fire; Poria cocos then can heart-spleen boosting, tranquilizing mind; And umbellate pore furgus, can only excreting dampness diuresis.The fat-soluble part of rhizoma alismatis has obvious norcholesterol effect and study of anti-atherogenic effect to experimental hypercholesterolemicrabbits rabbit, by the acetic acid esters of the alisol A be wherein separated, B and alisol A, B, C, except alisol B, there is the norcholesterol effect shown.Content with 0.1% adds in the feed of experimental atherosclerosis rats, and cholesterolemia can be made to decline more than 50%, wherein the strongest with the effect of alisol A-24-acetic acid esters.The ethanol extract of rhizoma alismatis, the ethyl acetate extract etc. of ethanol extract, have effect for reducing blood fat to experimental hypercholesterolemicrabbits rabbit and rat.Ethyl acetate extract is the strongest with its residual fraction effect be insoluble in acetic acid one water.Ethyl acetate extract oral 1g/kg every day, also has obvious norcholesterol effect to raising with the normal rat of normal diet.Prove by coordination list notation method, alisol A has the ability suppressing mouse small intestine esterified cholesterol, and the absorptivity of cholesterol in rat small intestine can be made to reduce by 34%, but does not affect linoleic absorption.
Cape jasmine: another name Yellow Fructus Gardeniae, mountain Cape jasmine, white toad are the fruits of madder wort cape jasmine.At present, the fruit of cape jasmine is traditional Chinese medicine, belongs to the 1st batch of medicine-food two-purpose resource that the Ministry of Public Health promulgates, has effects such as protecting liver, cholagogic, step-down, calmness, hemostasis, detumescence.The diseases such as treatment icteric hepatitis, bruise, hypertension, diabetes are usually used at tcm clinical practice.Heat-clearing, purging intense heat, cool blood.Control pyreticosis restlessness of asrhenia type and insomnia, jaundice, gonorrhoea, quench one's thirst, hot eyes, pharyngalgia, spit blood, bleeding from five sense organs or subcutaneous tissue, bloody flux, hematuria, pathopyretic ulcer, sprains and swells and ache
Selfheal selfheal is cold in nature, sweet, pungent, the micro-hardship of taste, there is the effect of letting out clearly irascibility, mass dissipating and swelling eliminating, clearing heat and detoxicating, expelling phlegm and arresting coughing, cooling blood and hemostasis, under being applicable to scrofula, goitre, acute mastitis, vertigo, facial paralysis, arthralgia and myalgia, pulmonary tuberculosis, metrorrhagia, band, Fiedeler's disease type hepatitis and bacillary dysentery etc.Modern pharmacological research shows, selfheal has the effect reduced blood pressure, and energy hemangiectasis, contained by it, rutin has antiinflammatory action, and can reduce vasopermeability, reduces fragility, reduces liver fat.Selfheal also has the effect of resisting cancer cell." herbal classic ": main fever and chills, scrofula, mouse fistula, head sore, broken disease, loose goitre knot gas, pin swells arthritis with fixed pain caused by dampness." Amplification on Materia Medica addendum ": take a tonic or nourishing food to build up one's health blood vessels." the southern regions of the Yunnan Province book on Chinese herbal medicine ": liver wind of dispelling, network of passing through, controls facial paralysis.Row irritability, opens liver depression, only arthralgia and myalgia, ophthal malgia, and loose scrofula is stolen, whole body tuberculosis.
Gynostemma pentaphylla has adaptive capacity widely, has significant inhibitory action to multiple cancer cell; In addition, gynostemma pentaphylla also has reducing blood lipid, hypotensive, hypoglycemic, calm, hypnosis, anti-anxiety, antiulcer, antifatigue, prolongation cell survival and improves a poor appetite, build up resistance, unobstructed stool, antiasthmatic-antitussive, the hemorrhoid that disappear, fat-reducing, the treatment chronic diseases marked by deficiency of vital energy, suppression gall stone are formed, prevent and treat glucocorticoid side effect, anti-ageing multiple efficacies of waiting for a long time.Except the effect with ginseng, also there is the multiple effect that ginseng does not possess, and there is no reaction and any other toxic and side effect of ginseng excessive use.
The Radix Astragali is based on qi-restoratives, and energy invigorating qi for strengthening superficies, diuresis holder is malicious, apocenosis, expelling pus and promoting granulation.For insufficiency of vital energy and blood, sore caves in, purulence one-tenth is not burst or of a specified duration bursting does not hold back person.The Radix Astragali has the function of good promoting pus discharge and tissue regeneration, i.e. the abscess suppuration myogenic of disunion for a long time.Modern medicine study shows, the Radix Astragali includes and multiple antibiotic effective ingredient, and can strengthen the immunologic function of body, therefore can also be used for the generation preventing some infectious disease." book on Chinese herbal medicine meets former " carries: " all void of Radix Astragali energy tonifying five zang organs, controls arteries and veins string spontaneous perspiration, rush down yin fire, remove lung heat, lossless, sends out, has sweat then to stop." be the good medicine promoting resistance and defence disease.
Specific embodiment 1:
Pluck Folium Apocyni Veneti in annual early June to late October in annual summer, plucked to spread out and shone or dry, sieve discarding stalk, raises clean impurity, puts into iron pan and knead, then Titian.
Again by all the other raw material rhizoma alismatis, motherwort, giant knotweed, cassia seed, Canton love-pea vine, hawthorn, turmeric, cape jasmine, parasitic loranthus, sophora flower, the fruit of glossy privet, polygala root, gynostemma pentaphylla, selfheal, lotus leaf, the root of herbaceous peony, the Radix Astragali adds water or alcohol extract makes granule, pulvis or paste.
Mixed with the pulvis obtained, granule or paste by the Folium Apocyni Veneti prepared, ultraviolet radiation for sterilizing and disinfecting is bottled.
Specific embodiment 2:
To gather in annual summer Folium Apocyni Veneti in annual early June to late October, plucked to spread out and shone or dry, sieve discarding stalk, raises clean impurity, first kneads 10-15 minute with the little fire of iron pan, be then put into fragrance extracting machine Titian 10-20 minute.About 5000g.Get other raw material rhizoma alismatis 1500g again, motherwort 1500g, giant knotweed 1500g, cassia seed 1500g, Canton love-pea vine 1500g, hawthorn 1500g, turmeric 1500g, cape jasmine 1500g, parasitic loranthus 1500g, sophora flower 1500g, fruit of glossy privet 1500g, polygala root 1500g, gynostemma pentaphylla 1500g, selfheal 1500g, lotus leaf 1500g, root of herbaceous peony 1500g, Radix Astragali 1500g, add in the ethanol of 5-10 times amount and soak 1-2 hour, heating extraction 2 times, each 1-2 hour, remove supernatant, merge extract, 100-120 order filters, be the ultrafiltration post ultrafiltration of 5000-10000 again through the molecular weight that dams, when ultrafiltrate reduced pressure concentration relative density is 80 DEG C 1.36 medicinal extract, heating is concentrated into paste, stand for standby use, inserted in economic benefits and social benefits vacuum concentrator again, when being concentrated into 90 DEG C, relative density is the concentrate of 1.50, set to 0 ~ 5 DEG C of deepfreezes 24 hours, refrigeration liquid is added the filter aid diatomite of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, be concentrated into every 1ml containing 0.2g crude drug amount, then add dextrin mediation to granulate, then mixed with the granule obtained by the Folium Apocyni Veneti prepared, ultraviolet radiation for sterilizing and disinfecting is bottled.
Specific embodiment 3:
To gather in annual summer Folium Apocyni Veneti in annual early June to late October, plucked to spread out and shone or dry, sieve discarding stalk, raises clean impurity, first kneads 10-15 minute with the little fire of iron pan, be then put into fragrance extracting machine Titian 10-20 minute.About 4000g.Get other raw material rhizoma alismatis 1200g, motherwort 1300g, giant knotweed 1200g, cassia seed 1200g again, Canton love-pea vine 1200g, hawthorn 1200g, turmeric 1200g, cape jasmine 1300g, parasitic loranthus 1200g, sophora flower 1200g, fruit of glossy privet 1100g, polygala root 1200g, gynostemma pentaphylla 1200g, selfheal 1200g, lotus leaf 1300g, root of herbaceous peony 1200g, Radix Astragali 1200g, get bulk drug clean dry, in 70 DEG C of baking ovens, dry 1-3h, take out and be placed in cooling in drying box, pulverized 80-100 mesh sieve with pulverizer.The Folium Apocyni Veneti be mixed with, one bubbles in ethanol after 1-2 days, heating extraction 2 times, each 1-2 hour, remove supernatant, merge extract, 100-110 order filters, be the ultrafiltration post ultrafiltration of 6000-10000 again through the molecular weight that dams, when ultrafiltrate reduced pressure concentration relative density is 80 DEG C 1.36 medicinal extract, heating be concentrated into paste, insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 90 DEG C, relative density is the concentrate of 1.50, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Refrigeration liquid is added the filter aid diatomite of 0.3%, filter, filtrate is inserted in economic benefits and social benefits vacuum concentrator again, be concentrated into every 1ml containing 0.5g crude drug amount, make paste, then the Folium Apocyni Veneti prepared is mixed with the paste obtained, ultraviolet radiation for sterilizing and disinfecting bottling ultraviolet disinfection, bottling.
Specific embodiment 4:
To gather in annual summer Folium Apocyni Veneti in annual early June to late October, pluck to spread out and shone or dry, sieve discarding stalk, raise clean impurity, first knead 10-15 minute with the little fire of iron pan, then fragrance extracting machine Titian 10-20 minute is put into, about 4200g, get other raw material rhizoma alismatis 1200g again, motherwort 1300g, giant knotweed 1200g, cassia seed 1200g, Canton love-pea vine 1200g, hawthorn 1200g, turmeric 1200g, cape jasmine 1300g, parasitic loranthus 1200g, sophora flower 1200g, fruit of glossy privet 1100g, polygala root 1200g, gynostemma pentaphylla 1200g, selfheal 1200g, lotus leaf 1300g, root of herbaceous peony 1200g, Radix Astragali 1200g, be mixed and put into acid and alkali-resistance infusion kettle, at room temperature, 3 ~ 7 days are flooded together with more than 70 degree ethanol, then heating and refluxing extraction 2 times, each 1 ~ 2 hour, No. 2 extracts are merged and leaves standstill, filter, filtrate is got after separation, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, and merge leaching liquor, being condensed into pasty state becomes component 2, by component 1 and component 2-in-1 and after, insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the paste of 1.60, paste after concentrated is put into drying machine and is dried to pulvis, again the Folium Apocyni Veneti prepared is mixed with the pulvis obtained, ultraviolet radiation for sterilizing and disinfecting bottling ultraviolet disinfection, bottling.
Pharmacological toxicity is tested
Experimental example 1: acute toxicity test of the present invention
One, test material: animal: Kunming mouse, body weight 18-25g, male and female half and half, Shandong University's biology laboratory breeding.Medicine: the present invention's (all raw material mixing decoction 2 times merges and filters, taking liquid) is containing 0.0365mg/ml.
Two, method:
1, LD50 calculates: adopt improvement karber's method, mouse is divided into 5 groups at random, often organize 10, male and female half and half, dissolve adding distil water of the present invention, are made into Cmax, by the administration of mouse maximum permission capacity, institute is followed successively by 18,14.4 to dosage by crude drug amount, 11.5,9.2,7.4 (g.kg-1), in animal fasting (can't help water) after 18 hours, administration at twice in one day (interval half an hour), each 0.5ml, observes animal dead situation.
2, maximum tolerated dose measures (MTD value): get mouse 20, each 10 of male and female.Adding distil water of the present invention is dissolved, is made into maximum concentration, by the maximal tolerance dose of animal, feed device and can twitch to inject to fill with and be as the criterion.In animal fasting (can't help water) after 18 hours, administration at twice in one day (interval half an hour), each 0.5ml (every ml containing crude drug 0.36g), total dose is 18g crude drug/kg.d, 300 times of quite clinical adult 50Kg body weight consumption.Continuous Observation 7 days after administration.
Three, result of the test:
In LD50 calculates when giving mouse with maximum acceptable concentration and maximum permission capacity (18g/Kg.d), have no dead mouse, namely LD50 is not measured, ask maximum tolerated dose only, in 7 day observation period, its appetite of animal, activity, hair color, the state of mind etc. are all normal, grow normal, there are no death.Namely select the 300 times of doses being equivalent to clinical dosage, and have no adverse reaction, show that acute toxicity is minimum, MTD > 18g/Kg.d.
Experimental example 2: the result of the test of acute toxicity and long term toxicity
Acute toxicity test: give the present invention by the disposable gavage of small white mouse, maximum concentration 35%, maximum gavage capacity 0.4ml/10g, dosage 14g/kg (every g medicinal powder is equivalent to 10g crude drug), Continuous Observation 7 days, do not find any toxic reaction, because concentration and dosage cannot increase, therefore fail to measure the LD 50 of this medicine.Maximum tolerance determination: with maximum concentration, maximum gavage capacity, mice lavage administration 3 times, 5 hours, interval, then Continuous Observation 7 days, none example is dead.Medicinal powder dosage is > 42g/kg. day (every g medicinal powder is equivalent to 10g crude drug), calculates 420 times of the clinical consumption per day that is equivalent to be grown up by kg body weight.
Long term toxicity test: whether produce toxic reaction for observing long-term prescription, give rat the present invention respectively and raise clothes, by adult 70 times of clinical consumption per day and 35 times (i.e. 7g/kg/ day and 3.5g/kg/ day), give continuously and feed 8 weeks, have no the behavior of rat, feed, body weight appearance extremely, with control group ratio, routine blood test, hepatic and renal function, the change all without exception of various important organ, within the scope of institute's dosage, do not find any toxicity of the present invention.Confirmed by the acute and chronic toxicity test of animal, safe range of the present invention is comparatively large, is a kind of safe and reliable health products.
Pharmacological experiment:
Observe the present invention to the impact of animal used as test blood pressure and blood lipoid.Method: adopt the diabetic mouse model caused by alloxan, with streptozotocin mycin (STZ) and the method giving high caloric diet copies type ii diabetes rat model, treat respectively with the present invention, Glipizide, then claim its body weight, measure serum triglyceride, cholesterol, serum insulin content and carry out dextrose tolerance test.Result: the present invention obviously reduces the blood sugar of diabetic mice, alleviates the body weight of diabetes B rat, stops fat generation.Also can reduce Peripheral Blood insulin level simultaneously, improve the ubiquitous notable feature of this diabetes B of insulin resistance.Conclusion: the present invention has obvious hypoglycemic lipid-lowering effect.
1 materials and methods
1.1 animals used as test: Wister rat, male, body weight 200 ~ 250g; Every only about the 18 ~ 20g of Kunming mouse (male and female dual-purpose), above animal is the biological animal center of Shandong University and provides.
1.2 high-calorie feed: mixed with sucrose, refining lard by basal feed, its total amount of heat is 20.08KJ/g (protein 15%, carbohydrate 51%, fat 25%).
1.3 medicines and reagent: the present invention: Folium Apocyni Veneti 40g, rhizoma alismatis 12g, motherwort 13g, giant knotweed 11g, cassia seed 11g, Canton love-pea vine 11g, hawthorn 11g, turmeric 12g, cape jasmine 14g, parasitic loranthus 12g, sophora flower 11g, fruit of glossy privet 12g, polygala root 12g, gynostemma pentaphylla 13g, selfheal 12g, lotus leaf 12g, root of herbaceous peony 11g, Radix Astragali 12g, (purchased from Shandong College of Traditional Chinese Medicine's Baokang hospital clinic), make after water decoction-alcohol sedimentation 100% liquid for subsequent use.STZ is Sigma Products, lot number: S0130; Alloxan is Sigma Products, faces the used time is made into 1% solution with citric acid one sodium citrate buffer solution of 0.1mmol/L, pH4.2; Glipizide tablet is Hainan Jin Xiao pharmaceutical Co. Ltd product, lot number: 001213; Blood sugar kit, Cholesterol Kit, Triglyceride Reagent box and serum insulin radioimmunological kit are all purchased from Beijing Zhongsheng Biological Engineering High Technology Company.
1.4 laboratory apparatus: semi-automatic biochemical analyzer: EPPENDORF-F6124 type, Germany; Radioimmunoassay instrument: naval's Medical Devices head factory, China.
The preparation of 1.5 experimental models: the preparation of diabetic hyperlipemia rat model: rat tail vein fast injection STZ30mg/kg, feeds with basal feed, freely drinks water, and tail vein blood after 2 weeks, carries out dextrose tolerance test; Select impaired glucose tolerance rat to feed with Prof. Du Yucang high-calorie feed, continue nursing 2 months.
The preparation of diabetic mouse model: get Kunming mouse, fasting 10h, then tail vein injection alloxan 100mg/kg, gets blood from mouse orbit after 72h, surveys blood glucose value; Blood glucose value is modeling success more than 11.0mmol/L person, for later experiment.
1_6 observation index and method: body weight: weigh with the electronic scale that Sartorius (Germany) produces.Blood sugar: GOD-PAP method.Serum triglyceride: GPO-PAP method.Serum cholesterol: CH013-PAP method.Above 3 indexs, all by the operation of medicine box description, are produced EPPENDORF-F6124 type semi-automatic biochemical analyzer with Germany and are measured.Serum insulin is with putting the method for exempting from, and by specification operates.
1.7 data processings: experimental data represents with-X ± S, data statistics validity adopts t inspection.
2 experimental results
2.1 the present invention are on the impact of normal mouse blood sugar: get mouse 30, random point 3 groups: normal group, of the present invention group (5g/kg) and Glipizide group (1.3mg/kg).The morning every day gastric infusion, continuous 14d, fasting 6h after last administration, in mouse orbit get blood survey blood sugar.Result shows, the present invention has hypoglycemic activity (P > 0.05) to normal mouse.In table 1.
Table 1 the present invention is on the impact of normal mouse blood sugar.(x±s)
| Group | N | Blood sugar mmol/L |
| Normal group | 10 | 6.21±1.34 |
| Of the present invention group | 10 | 5.33±1.18* |
| Glipizide group | 10 | 5.29±0.86** |
Note: compare with normal group, * P > 0.05, * * P < 0.01
2.2 the present invention are on the impact of alloxan diabetes mouse: get normal mouse 10, survey its blood glucose value, feed with conventional feed.Separately get into mould mouse 50, be divided into 5 groups at random, be i.e. model group, of the present invention group (high, medium and low dosage group) and Glipizide group, successive administration 14d.Above 6 groups of mouse orbits are got blood, are surveyed its blood glucose value by 1h after last administration.
Result shows, give with alloxan after, model group compared with normal control group mice blood sugar level significantly raises, and still maintains higher level to experiment 14d its blood sugar.Of the present invention group of blood sugar level is starkly lower than model group, shows that the present invention can make alloxan diabetes mouse blood sugar reduce (P < 0.05), but still higher than Normal group (P < 0.05).In table 2.
Table 2 the present invention is on the impact (x ± s) of alloxan diabetes mouse blood sugar
Note: compare with normal group, * P < 0.05, * * * P < 0.01; Compare with model group, △ P < 0.05, △ △ △ P < 0.001
2.3 the present invention are to the effect of diabetic hyperlipemia rat
2.3.1 the present invention is on the impact of diabetic hyperlipemia rat body weight: grouping, administration is the same, day administration 1 time, continuous gavage 30 days.Experimental session drinking water for animals and feed without restriction.
Result shows, model group body weight is apparently higher than normal group (P < O.01), of the present invention group and Glipizide group body weight are starkly lower than model group (P < 0.01, P < 0.05), of the present invention group and Glipizide group compare indifference (P > 0.05, P > 0.05) with normal group.Illustrate that the present invention has the effect of certain reduction rat model body weight.In table 3.
Table 3 the present invention is on the impact (x ± s) of diabetic hyperlipemia rat body weight
| Group | N | Dose | Body weight (g) |
| Normal group | 10 | -- | 246.00±15.84 |
| Model group | 10 | -- | 316.5±18.31** |
| Of the present invention group (low) | 10 | 5g/kg | 285.64±15.31△ |
| Of the present invention group (in) | 10 | 10g/kg | 281.26±18.31△△ |
| Of the present invention group (height) | 10 | 15g/kg | 271.48±17.42△△ |
| Glipizide group | 10 | 1.3mg/kg | 271.67±19.65△ |
Note: compare with normal group, * * P < 0.01; △ P < 0.05, △ △ P < 0.01 is compared with model group
2.3.2 the present invention is on the impact of diabetic hyperlipemia rat glucose tolerance: grouping is the same with administration.Rat Fast 8h, intraperitoneal injection 1.11mol/L glucose solution 2g/kg, docking is got blood and is surveyed (0), 30,60 and 120min blood glucose value at once.Check through t, model group IGT (compares with 120min at once, P < 0.05), Analysis of variance, this group 30,60 and 120min blood sugar are apparently higher than normal group (P < 0.001, P < 0.01 and P < 0.05).Of the present invention group 30 and 60min are significantly higher than normal group (P < 0.001, P < 0.01), but be also starkly lower than model group (P < 0.01, P < 0.05), and normal glucose tolerance (at once comparing with 120min, P > 0.05).In table 4.
Table 4 the present invention is on the impact (x ± s) of diabetic hyperlipemia rat glucose tolerance
Note: compare with normal group, * P < 0.05, * * P < 0.01, * * * P < 0.001; Compare with model group, △ P < 0.05, △ △ P < 0.01; At once compare with this group, ▲ P < 0.05.
2.3.3 the present invention is on the impact of diabetic hyperlipemia rat blood serum triglycerides, cholesterol: grouping, administration is the same.Result shows, the obvious rising of model group serum triglyceride, cholesterol and normal group (P < 0.001, P < 0.001); Two places soup is respectively organized all higher than normal group (P < 0.01, P < 0.001), but is starkly lower than model group (P < 0.001, P < 0.001); Glipizide is all apparently higher than control group (P < 0.001, P < 0.001), but no significant difference (P > 0.05, P > 0.05) is compared with model group.Illustrate that the present invention has certain reduction serum triglyceride, the effect of cholesterol, row pyrazine does not but have this to act on.In table 5.
Table 5 the present invention is on the impact (x ± s) of diabetic hyperlipemia rat blood serum triglycerides, cholesterol
Note: compare with normal group, * P < 0.01, * * P < 0.001; Compare with model group, △ P < 0.001
2.3.4 the present invention is on the impact of diabetic hyperlipemia rat blood serum insulin: grouping, administration is the same.Result shows, model group serum insulin is apparently higher than normal group (P < 0.01); The present invention respectively organizes and is starkly lower than model group (P < 0.05 with Glipizide group, P < 0.05), but also higher than normal group (P < 0.05, P < 0.05).Illustrate that the present invention has the effect of certain reduction serum insulin, this effect is similar to Glipizide.In table 6.
Table 6 the present invention is on the impact (x ± s) of diabetic hyperlipemia rat blood serum insulin
| Group | N | Dose | Insulin μ IU/ml |
| Normal group | 10 | -- | 22.84±2.42 |
| Model group | 10 | -- | 28.11±2.41** |
| Of the present invention group (low) | 10 | 5g/kg | 25.58±1.33*△ |
| Of the present invention group (low) | 10 | 10g/kg | 24.24±1.64*△ |
| Of the present invention group (low) | 10 | 15g/kg | 23.12±1.32*△ |
| Glipizide group | 10 | 1.3mg/kg | 24.06±1.48*△ |
Note: compare with normal group, * P < 0.01, * * P < 0.001; Compare with model group, △ P < 0.005
Experiment shows that the present invention obviously can reduce blood glucose in diabetic mice, but the blood sugar level of intact animal is not affected, its hypoglycemic mechanism has nothing to do with directly stimulating the effect of B cell excreting insulin, the damage of B cell may be alleviated with it, recover the impaired 26S Proteasome Structure and Function of pancreas islet and pass through relevant to glycometabolic adjustment.Also can reduce Peripheral Blood insulin level simultaneously, improve the ubiquitous feature of this diabetes B of insulin resistance.In addition, the present invention can alleviate the body weight of diabetes B rat, presses down the generation that resistance is fat, makes body weight can control, in normal scope, to reduce the hyperlipidemia that diabetes occur together.
Along with the life style of people, the change of working environment, the age distribution of high blood pressure is tending towards becoming younger, and normal with hyperlipidemia, and blood viscosity increases, cardio cerebrovascular affection etc.Hypertension with traditional Chinese Medical card class constantly changes, and finds that liver-Yang sthenia type hypertension is more and more higher at the happy disease rates of high blood, or develops into hypertensive Etiological.Along with going deep into of research, find that the etiology and pathogenesis of high blood pressure is with liver-yang hyperactivity, it is main that card is contained in the wet heap soil or fertilizer over and around the roots of phlegm. liver-yang hyperactivity occupies very important status in high blood pressure and complication morbidity, the present invention's drink is natural traditional Chinese medicine, be conceived to overall conditioning, be conducive to the treatment rate and the controlling of blood pressure rate that improve high blood pressure, increase the compliance of patient.
Chinese medicine can play assistant hypoglycemic step-down, lipopenicillinase, reduces Western medicine side effect, and reduce Western medicine intake, the effect of consolidate curative effect, as the health-care effect that health products supplemental treatment has had.In a word, though Chinese medicine hypoglycemic hypotensive effect does not have, Western medicine speed is fast, effect is strong, and more its effect harrows a little; while step-down, diabetes, other pathology links hypertensive can also be taken into account, have improve microcirculation, lipopenicillinase is anti-oxidant; protection endothelium, regulates the effects such as vaso-active substance.Therefore, Chinese medicine obviously can improve diabetes, hypertensive clinical symptoms, improves the quality of life of patient.Chinese medicine odor is poor, and a lot of people is reluctant long-term taking; Even if take, be medicine three points of poison, allow during people's long-term taking and also produce resisting psychology.Folium Apocyni Veneti is cold in nature. and taste is sweet, bitter, and flat liver is calmed the nerves, clearing away heat and promoting diuresis.Main component rutin sophorin, catechu rope, isoquercitrin rope, glutamic acid, alanine, valine, potassium chloride etc., wherein antihypertensive compositions is Quercetin, general flavone, have hypotensive, strengthen capillary resistance, reduce capillary fragility, fall that blood refers to, coronary artery dilator increases coronary blood flow effect.The micro-bitter glycol of the present invention; Add some promoting blood circulation and removing blood stasis, mouthfeel is light, makes people be easy to the Chinese medicine accepted, can reach effect of hypoglycemic preferably.
Claims (10)
1. the Folium Apocyni Veneti health protection tea of a hypoglycemic, it is characterized in that, described Folium Apocyni Veneti health protection tea comprises the raw material of following parts by weight: Folium Apocyni Veneti 10 ~ 50 parts, rhizoma alismatis 10 ~ 20 parts, motherwort 10 ~ 20 parts, giant knotweed 10 ~ 20 parts, cassia seed 10 ~ 20 parts, Canton love-pea vine 10 ~ 20 parts, hawthorn 10 ~ 20 parts, 10 ~ 20 parts, turmeric, cape jasmine 10 ~ 20 parts, parasitic loranthus 10 ~ 20 parts, 10 ~ 20 parts, sophora flower, the fruit of glossy privet 10 ~ 20 parts, polygala root 10 ~ 20 parts, gynostemma pentaphylla 10 ~ 20 parts, selfheal 10 ~ 20 parts, 10 ~ 20 parts, lotus leaf, the root of herbaceous peony 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts.
2. the Folium Apocyni Veneti health protection tea of hypoglycemic according to claim 1, it is characterized in that, in described Folium Apocyni Veneti health protection tea, the parts by weight of various raw material are: Folium Apocyni Veneti 10 ~ 40 parts, rhizoma alismatis 10 ~ 15 parts, motherwort 10 ~ 15 parts, giant knotweed 10 ~ 15 parts, cassia seed 10 ~ 15 parts, Canton love-pea vine 10 ~ 15 parts, hawthorn 10 ~ 15 parts, 10 ~ 15 parts, turmeric, cape jasmine 10 ~ 15 parts, parasitic loranthus 10 ~ 20 parts, 10 ~ 20 parts, sophora flower, the fruit of glossy privet 10 ~ 20 parts, polygala root 10 ~ 20 parts, gynostemma pentaphylla 10 ~ 20 parts, selfheal 10 ~ 20 parts, 10 ~ 20 parts, lotus leaf, the root of herbaceous peony 10 ~ 20 parts, the Radix Astragali 10 ~ 20 parts.
3. the Folium Apocyni Veneti health protection tea of described hypoglycemic according to claim 1, it is characterized in that, in described Folium Apocyni Veneti health protection tea, the parts by weight of various raw material are: Folium Apocyni Veneti 10 ~ 30 parts, rhizoma alismatis 10 ~ 20 parts, motherwort 10 ~ 20 parts, giant knotweed 10 ~ 20 parts, cassia seed 10 ~ 20 parts, Canton love-pea vine 10 ~ 20 parts, hawthorn 10 ~ 20 parts, 10 ~ 20 parts, turmeric, cape jasmine 10 ~ 20 parts, parasitic loranthus 10 ~ 15 parts, 10 ~ 15 parts, sophora flower, the fruit of glossy privet 10 ~ 15 parts, polygala root 10 ~ 15 parts, gynostemma pentaphylla 10 ~ 15 parts, selfheal 10 ~ 15 parts, 10 ~ 15 parts, lotus leaf, the root of herbaceous peony 10 ~ 15 parts, the Radix Astragali 10 ~ 15 parts.
4. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic as described in any one of claims 1 to 3 item, it is characterized in that, the preparation process of described Folium Apocyni Veneti health protection tea comprises following aspect:
A. Folium Apocyni Veneti harvesting, knead, Titian;
B. heat extraction 2 times by all the other raw material soaking ethanol described, dregs of a decoction extracting in water 2 times again, merges;
C. the concentrate concentrated extract of all the other raw materials is become medicinal extract, add honey or dextrin makes granule, pulvis or paste;
D. granule, pulvis or paste that the Folium Apocyni Veneti prepared and above-mentioned steps obtain are mixed, pack after ultraviolet sterilization.
5. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic according to claim 4, is characterized in that, in described step a, at annual harvesting in summer Folium Apocyni Veneti, plucked to spread out and shone or dry, sieve discarding stalk, raises clean impurity; First knead 10-15 minute with the little fire of iron pan, be then put into fragrance extracting machine Titian 10-20 minute.
6. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic according to claim 4, it is characterized in that, in described step b, all the other raw medicinal materials are mixed, steep in ethanol, soak more than 2 hours, add the alcohol extract 2 times of 8 times amount of Folium Apocyni Veneti gross weight, 6 times amount respectively, extraction time is 2 hours, 1 hour; Merge No. 2 extracts, extract is centrifugal by tubular type, obtains centrifugate, and centrifugate is crossed D 101 macroreticular resin and adsorbed, and first washes removal of impurities with water, then carries out wash-out with the ethanol of 70%, collects eluent, merges standing.
7. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic according to claim 4, is characterized in that, in described step c, above-mentioned steps is obtained extract, insert in economic benefits and social benefits vacuum concentrator, when being concentrated into 80 DEG C, relative density is the medicinal extract of 1.50, sets to 0 ~ 5 DEG C of deepfreezes 24 hours; Refrigeration liquid is added the filter aid diatomite of 0.3%, filter, medicinal extract is inserted in economic benefits and social benefits vacuum concentrator again, is concentrated into every 1ml containing 0.2g crude drug amount; Paste after concentrated adds dextrin or granule made by honey.
8. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic according to any one of claims 1 to 3, it is characterized in that, the step that city pulvis prepared by other raw materials can also be:
A, get other raw materials and put into ethanol and soak, heat is extracted 3 times;
B, extract is positioned in inspissator concentrated, is then dried to pulvis.
9. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic according to claim 8, is characterized in that, in described step a, to be soaked by all the other bulk drugs in ethanol 12 hours, then put into extractor heating and boil 1 hour, filter, filtrate is for subsequent use; Filter residue adds ethanol, and second time heating, boils 45 minutes, and filter, filtrate is for subsequent use; Filter residue adds ethanol again, and half an hour is boiled in third time heating, filters; Three filtrates be combined, by filtered through gauze, add 50-60% ethanol in residue, 60 DEG C-70 DEG C are continued lixiviate 2h, and every 10min stirs once, filtered through gauze, merge leaching liquor, are condensed into pasty state.
10. the preparation method of the Folium Apocyni Veneti health protection tea of hypoglycemic according to claim 8, it is characterized in that, in described step b, by the raw material pasty state liquid extracted, reducing pressure after reclaiming ethanol, it is concentrated to put into inspissator, by gained concentrate adjustment proportion to 1.46, decompression, the pasty state liquid after concentrated is put into drying machine and is dried to pulvis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510394023.XA CN104904964A (en) | 2015-07-07 | 2015-07-07 | Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510394023.XA CN104904964A (en) | 2015-07-07 | 2015-07-07 | Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104904964A true CN104904964A (en) | 2015-09-16 |
Family
ID=54074751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510394023.XA Pending CN104904964A (en) | 2015-07-07 | 2015-07-07 | Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104904964A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105145986A (en) * | 2015-09-18 | 2015-12-16 | 广西大学 | Health-care tea brewing agent preventing hypertension and preparation method thereof |
| CN105192209A (en) * | 2015-11-09 | 2015-12-30 | 青岛安倍康生物医药技术有限公司 | Health blood vessel softening salvia leaf tea and preparation method thereof |
| CN106063926A (en) * | 2016-07-26 | 2016-11-02 | 陆川县马坡镇金兴红砖厂 | A kind of hypoglycemic tea |
| CN106615385A (en) * | 2017-01-11 | 2017-05-10 | 永安市仁迈信息技术服务有限公司 | Medical health-care tea and preparation method thereof |
| CN109123019A (en) * | 2018-10-26 | 2019-01-04 | 郭磊 | A kind of health-preserving tea and preparation method thereof |
| CN112022913A (en) * | 2020-10-22 | 2020-12-04 | 山西振东五和健康科技股份有限公司 | Blood fat reducing granules and preparation method thereof |
| CN115349491A (en) * | 2022-07-25 | 2022-11-18 | 山东中医药大学 | Method for establishing animal model of normal high blood pressure phlegm-dampness accumulation syndrome |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
| CN103393959A (en) * | 2013-08-09 | 2013-11-20 | 田艺儿 | Blood lipid-lowering traditional Chinese medicine formulation and preparation method thereof |
| CN104206595A (en) * | 2014-08-27 | 2014-12-17 | 青岛恒波仪器有限公司 | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof |
| CN104365943A (en) * | 2014-11-24 | 2015-02-25 | 青岛恒波仪器有限公司 | Fructus sophorae tea with effect of reducing sugar and fat and preparation method thereof |
-
2015
- 2015-07-07 CN CN201510394023.XA patent/CN104904964A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437959A (en) * | 2002-02-10 | 2003-08-27 | 杨志东 | Chinese prepartory for treating cardiovascular and cerebrovascular disease and preparation method |
| CN103393959A (en) * | 2013-08-09 | 2013-11-20 | 田艺儿 | Blood lipid-lowering traditional Chinese medicine formulation and preparation method thereof |
| CN104206595A (en) * | 2014-08-27 | 2014-12-17 | 青岛恒波仪器有限公司 | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof |
| CN104365943A (en) * | 2014-11-24 | 2015-02-25 | 青岛恒波仪器有限公司 | Fructus sophorae tea with effect of reducing sugar and fat and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 庄瑞丰: "中药降血脂作用研究进展", 《河北医药》 * |
| 谭晓蕾等: "罗布麻茶的研究进展", 《中国现代中药》 * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105145986A (en) * | 2015-09-18 | 2015-12-16 | 广西大学 | Health-care tea brewing agent preventing hypertension and preparation method thereof |
| CN105192209A (en) * | 2015-11-09 | 2015-12-30 | 青岛安倍康生物医药技术有限公司 | Health blood vessel softening salvia leaf tea and preparation method thereof |
| CN106063926A (en) * | 2016-07-26 | 2016-11-02 | 陆川县马坡镇金兴红砖厂 | A kind of hypoglycemic tea |
| CN106615385A (en) * | 2017-01-11 | 2017-05-10 | 永安市仁迈信息技术服务有限公司 | Medical health-care tea and preparation method thereof |
| CN109123019A (en) * | 2018-10-26 | 2019-01-04 | 郭磊 | A kind of health-preserving tea and preparation method thereof |
| CN112022913A (en) * | 2020-10-22 | 2020-12-04 | 山西振东五和健康科技股份有限公司 | Blood fat reducing granules and preparation method thereof |
| CN115349491A (en) * | 2022-07-25 | 2022-11-18 | 山东中医药大学 | Method for establishing animal model of normal high blood pressure phlegm-dampness accumulation syndrome |
| CN115349491B (en) * | 2022-07-25 | 2023-09-15 | 山东中医药大学 | Method for establishing an animal model of normal high blood pressure and phlegm-dampness syndrome |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103719498B (en) | A kind of Siberian solomonseal rhizome health-care tea improving immunity and preparation method thereof | |
| CN104904964A (en) | Folium apocyni veneti health tea capable of decreasing sugar and lipid and preparation method thereof | |
| CN102784363B (en) | Traditional Chinese medicine composition for treating pancreatic cancer and preparation method thereof | |
| CN104435775A (en) | Chinese medicinal health-care spirit and preparation method thereof | |
| CN103749822B (en) | A kind of fruit of glossy privet hypertension and hyperlipemia health protection tea and preparation method thereof | |
| CN104305205B (en) | A kind of Semen Cuscutae oral liquid improving immunity and preparation method thereof | |
| CN105454576A (en) | Jasmine-flower-comprising assorted Chinese herbal tea and preparation method thereof | |
| CN103301413A (en) | Traditional Chinese medicine composition for treating hyperlipemia and hyperglycemia | |
| CN104365943A (en) | Fructus sophorae tea with effect of reducing sugar and fat and preparation method thereof | |
| CN104206594A (en) | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof | |
| CN103735835A (en) | Traditional Chinese medicinal preparation for treating premature graying and preparation method thereof | |
| CN105124078A (en) | Gardenia blood-glucose-reducing and lipid-reducing healthcare tea and preparing method thereof | |
| CN108277138A (en) | A kind of health-care and nutritious wine and preparation method thereof | |
| CN103749819B (en) | Fructus Corni health protection tea of a kind of hypoglycemic and preparation method thereof | |
| CN103749824A (en) | Gynostemma pentaphyllum health-care tea capable of lowering blood sugar and blood pressure and preparation method thereof | |
| CN104206595A (en) | Blood lipid and blood glucose reducing Chinese wolfberry root-bark health care tea and preparation method thereof | |
| CN104304602A (en) | Pagoda tree fruit tea capable of softening blood vessels and preparation method thereof | |
| CN103705860B (en) | A kind of Chinese medicine composition for the treatment of infant jaundice and preparation method thereof | |
| CN105343593A (en) | Spica prunellae health oral liquid capable of decreasing blood pressure and blood lipid as well as preparation method of spica prunellae health oral liquid | |
| CN104906403A (en) | Folium apocyni veneti health oral liquid capable of decreasing blood pressure and lipid and preparation method thereof | |
| CN105211441A (en) | Red sage root leaf health-care tea of a kind of hypertension and hyperlipemia and preparation method thereof | |
| CN105455125A (en) | Arillus longan oral solution capable of improving immunity, and preparation method for oral solution | |
| CN105341944A (en) | Salvia miltiorrhiza oral liquid for improving immunity and preparation method thereof | |
| CN104888158A (en) | Folium apocyni veneti oral liquid for enhancing immunity and preparation method thereof | |
| CN104397282A (en) | Tranquilization and brain tonifying eleutherococcus senticosus healthare tea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150916 |
|
| RJ01 | Rejection of invention patent application after publication |